Terms: = Breast cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2
273 results:
1. A lipo-polymeric hybrid nanosystem with metal enhanced fluorescence for targeted imaging of metastatic breast cancer.
Appidi T; Sivasankaran RP; Chinchulkar SA; Patra P; Murugaiyan K; Veeresh B; Rengan AK
Nanotheranostics; 2024; 8(2):239-246. PubMed ID: 38444742
[TBL] [Abstract] [Full Text] [Related]
2. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
3. "All in one" nanoprobe Au-ttf-1 for target FL/CT bioimaging, machine learning technology and imaging-guided photothermal therapy against lung adenocarcinoma.
Yang Z; Zhang Y; Tang L; Yang X; Song L; Shen C; Zvyagin AV; Li Y; Yang B; Lin Q
J Nanobiotechnology; 2024 Jan; 22(1):22. PubMed ID: 38184620
[TBL] [Abstract] [Full Text] [Related]
4. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
5. Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia.
Livori AC; Ademi Z; Ilomäki J; Pol D; Morton JI; Bell JS
Eur J Prev Cardiol; 2024 Mar; 31(5):580-588. PubMed ID: 37987181
[TBL] [Abstract] [Full Text] [Related]
6. Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer.
Li X; Zhang Y; Zhang T; Zhao L; Lin CG; Hu H; Zheng H
Cancer Gene Ther; 2024 Jan; 31(1):69-81. PubMed ID: 37935981
[TBL] [Abstract] [Full Text] [Related]
7. Hormone Receptor Signaling and breast cancer Resistance to Anti-Tumor Immunity.
Moisand A; Madéry M; Boyer T; Domblides C; Blaye C; Larmonier N
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894728
[TBL] [Abstract] [Full Text] [Related]
8. A Population-Based Research Utilized a Risk Stratification Model to Forecast the Overall Survival of Young Women With Diagnosed Stage IV breast cancer.
Tang W; Shao M; Fang W; Wang J; Fu D
Clin Breast Cancer; 2023 Dec; 23(8):e523-e533. PubMed ID: 37741796
[TBL] [Abstract] [Full Text] [Related]
9. Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study.
King CB; Bychkovsky BL; Warner ET; King TA; Freedman RA; Mittendorf EA; Katlin F; Revette A; Crookes DM; Maniar N; Pace LE
BMC Prim Care; 2023 Aug; 24(1):165. PubMed ID: 37626335
[TBL] [Abstract] [Full Text] [Related]
10. Towards estimating the carbon footprint of external beam radiotherapy.
Chuter R; Stanford-Edwards C; Cummings J; Taylor C; Lowe G; Holden E; Razak R; Glassborow E; Herbert S; Reggian G; Mee T; Lichter K; Aznar M
Phys Med; 2023 Aug; 112():102652. PubMed ID: 37552912
[TBL] [Abstract] [Full Text] [Related]
11. Lung cancer with breast metastasis: a case report and review of the literature.
Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
[TBL] [Abstract] [Full Text] [Related]
12. The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation.
Zheng J; Liu J; Yang W; Yao J; Guo J; Liu C
World J Surg Oncol; 2023 Jun; 21(1):181. PubMed ID: 37337182
[TBL] [Abstract] [Full Text] [Related]
13. Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer.
Rommasi F
Sci Rep; 2023 May; 13(1):8447. PubMed ID: 37231064
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of renal clearance of [
Liu J; Guo X; Wen L; Wang L; Liu F; Song G; Zhu H; Zhou N; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2775-2786. PubMed ID: 37093312
[TBL] [Abstract] [Full Text] [Related]
15. Nanomedicine in therapeutic warfront against estrogen receptor-positive breast cancer.
Aalhate M; Mahajan S; Singh H; Guru SK; Singh PK
Drug Deliv Transl Res; 2023 Jun; 13(6):1621-1653. PubMed ID: 36795198
[TBL] [Abstract] [Full Text] [Related]
16. MobileNet-SVM: A Lightweight Deep Transfer Learning Model to Diagnose bch Scans for IoMT-Based Imaging Sensors.
Ogundokun RO; Misra S; Akinrotimi AO; Ogul H
Sensors (Basel); 2023 Jan; 23(2):. PubMed ID: 36679455
[TBL] [Abstract] [Full Text] [Related]
17. Endocrine therapy initiation and overall survival outcomes with omission of radiation therapy in older Medicare patients with early-stage hormone-receptor-positive breast cancer.
Shen C; Li N; Zhou S; Stahl K; Dodge D; Zhao H
Cancer Med; 2023 Mar; 12(6):6935-6944. PubMed ID: 36428284
[TBL] [Abstract] [Full Text] [Related]
18. Recent advances in atezolizumab-based programmed death-ligand 1 (PD-L1) blockade therapy for breast cancer.
Ameri A; Tavakoli-Far B; Rostami M; Abedi Kiasari B; Sakhaei D; Saad Ahmed O; Forouzani F; Fazli Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109334. PubMed ID: 36327869
[TBL] [Abstract] [Full Text] [Related]
19. Cutaneous metastases of non-cutaneous neuroendocrine neoplasms: A histopathologic review of 15 cases.
Hobbs MM; Snow JT; Shachner TR; Sokumbi O
J Cutan Pathol; 2022 Nov; 49(11):960-970. PubMed ID: 36222210
[TBL] [Abstract] [Full Text] [Related]
20. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer.
Gupta U; Saren BN; Khaparkhuntikar K; Madan J; Singh PK
J Control Release; 2022 Aug; 348():1089-1115. PubMed ID: 35640765
[TBL] [Abstract] [Full Text] [Related]
[Next]
